Zynerba Pharmaceuticals

$4.09
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.19 (-4.44%) As of 6:20 PM UTC today

Why Robinhood?

You can buy or sell ZYNE and other stocks, options, and ETFs commission-free!

About ZYNE

Zynerba Pharmaceuticals, Inc. engages in the provision of pharmaceutically-produced transdermal cannabinoid therapies. It focuses on research and development of rare and near-rare neuropsychiatric conditions.

CEO
Armando Anido
Employees
26
Headquarters
Devon, Pennsylvania
Founded
2007
Market Cap
176.60M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
1.34M
High Today
$4.33
Low Today
$4.07
Open Price
$4.33
Volume
1.09M
52 Week High
$9.00
52 Week Low
$3.12

ZYNE Earnings

-$0.78
-$0.52
-$0.26
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 11, Pre-Market

You May Also Like

TU
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure